TITLE

Risk Factors for Community-Acquired Pneumonia among Persons Infecte with Human Immunodeficiency

AUTHOR(S)
Navin, Thomas R.; Rimland, David; Lennox, Jeffrey L.; Jernigan, John; Cetron, Marty; Hightower, Allen; Roberts, Jacqueline M.; Kaplan, Jonathan E.
PUB. DATE
January 2000
SOURCE
Journal of Infectious Diseases;1/1/2000, Vol. 181 Issue 1, p158
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Analyzes risk factors associated with community-acquired pneumonia among persons infected with HIV. Possible pulmonary damages caused by the antecedent infection; Relationship between the anti-fungal agent fluconazole and the protective effect of the drug to pneumonia; Genetic sequence distinct from the Pneumocystis carinii isolate.
ACCESSION #
5350437

 

Related Articles

  • 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children...  // MMWR: Morbidity & Mortality Weekly Report;4/28/95 Supplement RR-4, Vol. 44 Issue 16, p1 

    Presents the revised prevention guidelines for prophylaxis against Pneumocystis carinii pneumonia (PCP) for children infected with or perinatally exposed to human immunodeficiency virus (HIV). Recommendations including the prompt diagnosis of children born to HIV-infected women; Timing and...

  • Discontinuation of Primary Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic... Mussini, Cristina; Pezzotti, Patrizio; Govoni, Alessandra; Borghi, Vanni; Antinori, Andrea; d'Arminio Monforte, Antonella; De Luca, Andrea; Mongiardo, Nicola; Cerri, Maria Chiara; Chiodo, Francesco; Concia, Ercole; Bonazzi, Lucio; Moroni, Mauro; Ortona, Luigi; Esposito, Robert; Cossarizza, Andrea; De Rienzo, Bruno // Journal of Infectious Diseases;5/1/2000, Vol. 181 Issue 5, p1635 

    Examines the discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients infected with HIV-type 1 whose CD4[sup +] T cell counts have increased to 200 cells per cubic millimeter as a result of highly active antiretrovial therapy (HAART). ...

  • SIDA en niños y adolescentes. Un estudio de 34 autopsias en dos décadas. Ridaura-Sanz, Cecilia; De León-Bojorge, Beatriz; López-Corella, Eduardo // Acta Pediatrica de Mexico;nov/dic2007, Vol. 28 Issue 6, p270 

    Background. Autopsy studies in patients who died with AIDS provide an insight on the occurrence and diversity of tissue changes directly resulting from HIV infection and of the infectious complications, often with opportunistic organisms, associated with the disease. Material and methods. This...

  • Sulfa or Sulfone Prophylaxis and Geographic Region Predict Mutations in the Pneumocystis carinii... Huang, Laurence; Beard, Charles B.; Creasman, Jennifer; Levy, Deborah; Duchin, Jeffrey S.; Lee, Sherline; Pieniazek, Norman; Carter, Jane L.; del Rio, Carlos; Rimland, David; Navin, Thomas R. // Journal of Infectious Diseases;10/1/2000, Vol. 182 Issue 4, p1192 

    Reports on a prospective study of HIV-infected patients with confirmed Pneumocytis carinii pneumonia in three cities in the United States to determine factors associated with mutations in the P. carinii dihydropteroate synthase gene. Significance of geographic location as a risk factor for...

  • In Vitro Activity of Human Immunodeficiency Virus Protease Inhibitors against Pneumocystis carinii. Atzori, Chiara; Angeli, Elena; Mainini, Annalisa; Agostoni, Fiorenza; Micheli, Valeria; Cargnel, Antonietta // Journal of Infectious Diseases;5/1/2000, Vol. 181 Issue 5, p1629 

    Examines the in vitro activity of HIV protease inhibitors against Pneumocystis carinii. Effects of protease inhibitors on HIV-related P. carinii pneumonia; Influence of the induction of immune reconstitution by highly active antiretroviral therapy (HAART) on protease action; Implications for...

  • Trimethoprim-Sulfamethoxazole (TMP-SMZ) Dose Escalation versus Direct Rechallenge for Pneumocystis Carinii Pneumonia Prophylaxis in Human Immunodeficiency Virus-Infected Patients with Previous Adverse Reaction to TMP-SMZ. Leoung, Gifford S.; Stanford, James F.; Giordano, Michael F.; Stein, Allan; Torres, Ramon A.; Giffen, Carol A.; Wesley, Margaret; Sarracco, Tricia; Cooper, Ellen C.; Dratter, Valerie; Smith, Jeffery J.; Frost, Kevin R. // Journal of Infectious Diseases;10/15/2001, Vol. 184 Issue 8, p992 

    Trimethoprim-sulfamethoxazole (TMP-SMZ) is the most effective Pneumocystis carinii pneumonia (PCP) prophylactic agent, but adverse reactions are common among human immunodeficiency virus (HIV)—infected patients and limit its use. This randomized, double-blind controlled trial compared 2...

  • Temporal Trends and Factors Associated with Survival after Pneumocystis carinii Pneumonia in California, 1983–1992. Colford, John M.; Segal, Mark; Tabnak, Farzaneh; Chen, Mi; Sun, Richard; Tager, Ira // American Journal of Epidemiology;1997, Vol. 146 Issue 2, p115 

    The authors investigated quarterly trends in survival after the diagnosis of Pneumocystis carinii pneumonia for 19,607 patients in California in the decade from January 1, 1983, through December 31, 1992. Subjects included all cases for whom P. carinii pneumonia was the initial (and only)...

  • Pneumocystis colonisation is common among hospitalised HIV infected patients with non- Pneumocystis pneumonia. Davis, J L; Welsh, D A; Beard, C B; Jones, J L; Lawrence, G G; Fox, M R; Crothers, K; Morris, A; Charbonnet, D; Swartzman, A; Huang, L // Thorax;Apr2008, Vol. 63 Issue 4, p329 

    Background: When Pneumocystis DNA is recovered from respiratory specimens of patients without Pneumocystis pneumonia (PCP), patients are said to be colonised with Pneumocystis, although the significance of this state is unknown. Understanding risk factors for and outcomes of colonisation may...

  • Risk factors for infliximab-related pneumocystis pneumonia.  // Reactions Weekly;11/10/2007, Issue 1177, p4 

    The article deals with a study which investigated the association of infliximab with pneumocystis pneumonia. Researchers from Japan have found that coexisting pulmonary disease along with prednisolone dose are risk factors for infliximab-related pneumocystis jiroveci pneumonia. The findings are...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics